title: Drug Development of Therapeutic Monoclonal Antibodies.
abstract: Monoclonal antibodies (MAbs) have become a substantial part of many pharmaceutical company portfolios. However, the development process of MAbs for clinical use is quite different than for small-molecule drugs. MAb development programs require careful interdisciplinary evaluations to ensure the pharmacology of both the MAb and the target antigen are well-understood. Selection of appropriate preclinical species must be carefully considered and the potential development of anti-drug antibodies (ADA) during these early studies can limit the value and complicate the performance and possible duration of preclinical studies. In human studies, many of the typical pharmacology studies such as renal or hepatic impairment evaluations may not be needed but the pharmacokinetics and pharmacodynamics of these agents is complex, often necessitating more comprehensive evaluation of clinical data and more complex bioanalytical assays than might be used for small molecules. This paper outlines concerns and strategies for development of MAbs from the early in vitro assessments needed through preclinical and clinical development. This review focuses on how to develop, submit, and comply with regulatory requirements for MAb therapeutics.
authors.affiliation: Projections Research Inc., Phoenixville, PA, 19046, USA. DRMould@PRI-Home.net.
authors.forename: Diane R
authors.initials: DR
authors.lastname: Mould
authors.affiliation: College of Pharmacy, The University of Tennessee Health Science Center, Memphis, TN, USA.
authors.forename: Bernd
authors.initials: B
authors.lastname: Meibohm
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D004347:Drug Interactions; D064368:Healthy Volunteers; D006801:Humans; D018675:Toxicity Tests / Q000379:methods
chemical_list: D000911:Antibodies, Monoclonal